Jack A. Khattar Cognition Therapeutics Inc (CGTX) insider trading activity

CGTX Quotes by TradingView

Jack A. Khattar is Director of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 48,500 shares of CGTX, which is worth approximately $34,435. The most recent transaction as insider was on Jun 18, 2025, when has been sold 34,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 48.5K
234.48% 3M change
234.48% 12M change
Total Value Held $34,435

Jack A. Khattar Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 18 2025
BUY
Grant, award, or other acquisition
-
34,000 Added 41.21%
48,500 Common Stock
Jun 07 2024
BUY
Grant, award, or other acquisition
-
8,500 Added 36.96%
14,500 Common Stock
Jun 09 2023
BUY
Grant, award, or other acquisition
-
6,000 Added 50.0%
6,000 Common Stock

Also insider at

SUPN
SUPERNUS PHARMACEUTICALS, INC. Healthcare
President, CEO
SCPH
scPharmaceuticals Inc. Healthcare
JAK

Jack A. Khattar

Director
Rockville, MD

Track Institutional and Insider Activities on CGTX

Follow COGNITION THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

News

Receive news related to COGNITION THERAPEUTICS INC

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CGTX